| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 04/13/2005 | EP1521839A1 Methods of making viral particles having a modified cell binding activity and uses thereof |
| 04/13/2005 | EP1521835A1 Use of ahas mutant genes as selection marker in potato transformation |
| 04/13/2005 | EP1521832A2 Genes |
| 04/13/2005 | EP1521831A2 Transgenic animal expressing alzheimer's tau protein |
| 04/13/2005 | EP1521824A2 Nucleic acid-associated proteins |
| 04/13/2005 | EP1521822A2 Protein modification and maintenance molecules |
| 04/13/2005 | EP1521821A2 Method for preparing engineered tissue |
| 04/13/2005 | EP1521774A2 Truncated tau proteins |
| 04/13/2005 | EP1521766A2 SPLICEOSOME MEDIATED RNA i TRANS /i -SPLICING AND CORRECTION OF FACTOR VIII GENETIC DEFECTS USING SPLICEOSOME MEDIATED RNA TRANS SPLING |
| 04/13/2005 | EP1495301A4 Devices, methods and systems for collecting material from a breast duct |
| 04/13/2005 | EP1465912A4 Novel chimeric tnf ligands |
| 04/13/2005 | EP1438425A4 69583 and 85924,novel human protein kinase family members and uses therefor |
| 04/13/2005 | EP1390471A4 Method for autologous transplantation |
| 04/13/2005 | EP1339356B1 Tissue-engineered vascular structures |
| 04/13/2005 | EP1259593B1 Tooth progenitor cell and method for its production |
| 04/13/2005 | EP1242576B1 Stabilizing diluent for polypeptides and antigens |
| 04/13/2005 | EP1210441B1 Variants of the gamma chain of ampk, dna sequences encoding the same, and uses thereof |
| 04/13/2005 | EP1183353B1 Modified chimeric polypeptides with improved pharmacokinetic properties |
| 04/13/2005 | EP1090105B1 Non-embryonic ependymal neural stem cells and method for their isolation |
| 04/13/2005 | EP1012250A4 Regulation of gene expression in plants |
| 04/13/2005 | EP0956052B1 Chimeric retrovirus/adenovirus system |
| 04/13/2005 | EP0938555B1 Constructs and complexes of cyclin e |
| 04/13/2005 | EP0741782B1 Methods using eaa3 or eaa4 receptors |
| 04/13/2005 | EP0728210B1 Thrombin mutants |
| 04/13/2005 | CN1606696A Article handling system and method |
| 04/13/2005 | CN1606627A Corn processing method and useful transgenic plant therein |
| 04/13/2005 | CN1606626A Novel alkaline protease from bacillius sp. (DSM 14390) and washing and cleaning products comprising said novel alkaline protease |
| 04/13/2005 | CN1606619A Novel alkaline protease from bacillus gibsonii (DSM 14391) and washing and cleaning agents containing said novel alkaline protease |
| 04/13/2005 | CN1606618A Novel alkali protease formed by bacillus gibsonii (DSM 14393) and washing and cleaning agents containing said novel alkali protease |
| 04/13/2005 | CN1606615A Method for expanding hematopoietic stem cells |
| 04/13/2005 | CN1606614A Dermal replacement prepared from mesenchymal cells of hair follicle |
| 04/13/2005 | CN1606569A Human antibodies that have mn binding and cell adhesion-neutralizing activity |
| 04/13/2005 | CN1606567A Antimicrobial polypeptides from pseudoplectania nigrella |
| 04/13/2005 | CN1606565A Nucleic acids encoding recominant 56 and 82 kda antigens from gametocytes of eimeria maxima and their uses |
| 04/13/2005 | CN1606518A Article handling system and method |
| 04/13/2005 | CN1606456A Restricted expression lentiviral vectors |
| 04/13/2005 | CN1606453A Cripto blocking antibodies and uses thereof |
| 04/13/2005 | CN1605628A Human source anti-hepatitis A virus gene engineering antibody from CHO cell |
| 04/13/2005 | CN1196788C Assembly of wild-type and chimeric influenza virus-like particles (VLPS) |
| 04/13/2005 | CN1196787C Virulence genes and proteins and their use |
| 04/13/2005 | CN1196785C Beta-amyloid peptdie-binding proteins and polynucleotides encoding the same |
| 04/13/2005 | CN1196784C Promoter of human endoglin gene and its use |
| 04/12/2005 | US6878866 Eustomahaving deformed pistil and method for breeding the same |
| 04/12/2005 | US6878860 Comprises antisense nucleotides sequences transformed and expressed in tomato for controlling flowering; gene expression inhibition and tissue engineering |
| 04/12/2005 | US6878817 Low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 04/12/2005 | US6878808 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins and uses thereof |
| 04/12/2005 | US6878758 Polyhydroxyalkanoate compositions having controlled degradation rates |
| 04/12/2005 | US6878549 Generating expression vector for use as gene transfer tool |
| 04/12/2005 | US6878546 Activating fetal nucleus; obtain cells, separate nucleus, incubate with egg extract, monitor nuclear activity |
| 04/12/2005 | US6878544 Retinal cell lines with extended life-span and their applications |
| 04/12/2005 | US6878543 Cultures of GFAP+ nestin+ cells that differentiate to neurons |
| 04/12/2005 | US6878542 Using fluorescence-activated cell sorting to separate and recover mammlian progenitor cells |
| 04/12/2005 | US6878536 Phosphoriboxyl-pyrophosphate synthetase polypeptide |
| 04/12/2005 | US6878533 Enzymatic activity for use in the biosynthesis of lysine for use in foods |
| 04/12/2005 | US6878529 Compounds for the treatment of sexual dysfunction |
| 04/12/2005 | US6878527 Modified proteins |
| 04/12/2005 | US6878383 Compositions for regenerating tissue that has deteriorated, and methods for using such compositions |
| 04/12/2005 | US6878376 Modulate immunology response |
| 04/12/2005 | US6878375 HA-1 antigen |
| 04/12/2005 | US6878371 Isolating autologous bone marrow- mononuclear cells from the subject; and transplanting locally into the tissue an effective amount of the autologous bone-marrow mononuclear cells, resulting in formation of new blood vessels in tissue |
| 04/12/2005 | US6877514 Organ transplantation; administering a relatively large number of stem cells, combined with the creation of thymic space without the need for whole body irradiation; mixed chimerism can be formed without hematopoietic space-creating irradiation |
| 04/12/2005 | CA2417135C Chimeric pre-activated transcription factors |
| 04/12/2005 | CA2306634C Suspension packing cell lines for retrovirus vectors |
| 04/12/2005 | CA2267994C Truncated platelet-activating factor acetylhydrolase |
| 04/12/2005 | CA2250704C Glial cell line-derived neurotrophic factor receptor |
| 04/12/2005 | CA2074825C Chimeric chains for receptor-associated signal transduction pathways |
| 04/12/2005 | CA1341479C Hybrid single-chain plasminogen activators |
| 04/07/2005 | WO2005030982A2 Coordinated decrease and increase of gene expression of more than one gene using transgenic constructs |
| 04/07/2005 | WO2005030967A2 Crop plant cystatin proteinase inhibitors and methods of use |
| 04/07/2005 | WO2005030966A2 Regulation of plant biomass and stress tolerance |
| 04/07/2005 | WO2005030940A1 Highly bioactive and productive chicken embryo extract and method for preparation thereof |
| 04/07/2005 | WO2005030939A2 Method and composition for regulating expansion of stem cells |
| 04/07/2005 | WO2005030932A2 Igf-1 instructs multipotent adult cns neural stem cells to an oligodendroglial lineage |
| 04/07/2005 | WO2005030793A2 Antibodies which bind human cxcr3 |
| 04/07/2005 | WO2005030298A2 System for injecting liquid drug containing biological material |
| 04/07/2005 | WO2005030251A1 Compositions and methods to accelerate hematologic recovery |
| 04/07/2005 | WO2005030145A2 Composition and pharmacology of novel alpha-6-containing nicotinic acetylcholine receptors |
| 04/07/2005 | WO2005030136A2 Tumor vaccine |
| 04/07/2005 | WO2005030040A2 Hematopoietic stem cell identification and isolation |
| 04/07/2005 | WO2005016960A3 Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei |
| 04/07/2005 | WO2005012351A8 Novel functions for decay accelerating factor (daf) in inflammation |
| 04/07/2005 | WO2005010157A3 Use of pleiotrophin in the diagnosis, treatment and prevention of disease |
| 04/07/2005 | WO2005005621A3 NOVEL METHOD FOR THE PREPARATION OF EMBRYOID BODIES (EBs) AND USES THEREOF |
| 04/07/2005 | WO2005005601A8 Compositions and methods for treating and diagnosing cancer |
| 04/07/2005 | WO2005003334A3 Postpartum cells derived from umbilical cord tissue, and methods of making and using the same |
| 04/07/2005 | WO2004103067A3 A transgenic animal model for cancer and stem cells |
| 04/07/2005 | WO2004099394A3 A method for efficient transfer of human blastocyst-derived stem cells (hbs cells) from a feeder-supported to a feeder-free culture system |
| 04/07/2005 | WO2004096976A3 Spex compositions and methods of use |
| 04/07/2005 | WO2004048922A3 Bead-based detection of ligand-gpcr-g protein complexes |
| 04/07/2005 | WO2004023100A3 Cd56 positive human adult pancreatic endocrine progenitor cells |
| 04/07/2005 | WO2004013309A3 PAPSSs AS MODIFIERS OF THE AXIN PATHWAY AND METHODS OF USE |
| 04/07/2005 | WO2004010959A3 Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith |
| 04/07/2005 | WO2003093200A3 Method for synthesis of aryl-carotenoids |
| 04/07/2005 | WO2003090689A3 Neurodegenerative disorder treatment using gdnf secreting neural cells |
| 04/07/2005 | WO2003062395A3 Predictor sets for tyrosine kinase pathways |
| 04/07/2005 | WO2002066615A3 Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system |
| 04/07/2005 | WO2002045659A3 Novel therapeutics for heart failure and aging |
| 04/07/2005 | US20050076409 Selective plant growth using d-amino acids |
| 04/07/2005 | US20050076406 Plant-derived resistance gene |
| 04/07/2005 | US20050076399 Using nuclear transplantation as tool in generating transgenic swine model which expresses green fluorescent protein and is defeicient in 1, 3 glactosyltransferase activity; bioreactors and heterologous gene expression |